Bank of New York Mellon Corp - BIOSPECIFICS TECHNOLOGIES CO ownership

BIOSPECIFICS TECHNOLOGIES CO's ticker is BSTC and the CUSIP is 090931106. A total of 114 filers reported holding BIOSPECIFICS TECHNOLOGIES CO in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Bank of New York Mellon Corp ownership history of BIOSPECIFICS TECHNOLOGIES CO
ValueSharesWeighting
Q3 2020$3,174,000
-15.8%
60,062
-2.3%
0.00%0.0%
Q2 2020$3,768,000
+0.0%
61,485
-7.7%
0.00%0.0%
Q1 2020$3,767,000
-2.4%
66,598
-1.7%
0.00%0.0%
Q4 2019$3,858,000
+10.0%
67,754
+3.4%
0.00%0.0%
Q3 2019$3,506,000
-8.3%
65,522
+2.4%
0.00%0.0%
Q2 2019$3,822,000
+0.6%
64,006
+5.0%
0.00%0.0%
Q1 2019$3,801,000
-9.6%
60,978
-12.1%
0.00%0.0%
Q4 2018$4,205,000
+2.3%
69,376
-1.2%
0.00%0.0%
Q3 2018$4,109,000
+30.9%
70,251
+0.4%
0.00%0.0%
Q2 2018$3,140,000
+0.5%
69,975
-0.7%
0.00%0.0%
Q1 2018$3,124,000
+4.3%
70,476
+2.0%
0.00%0.0%
Q4 2017$2,994,000
-5.8%
69,079
+1.1%
0.00%0.0%
Q3 2017$3,178,000
-5.7%
68,324
+0.4%
0.00%0.0%
Q2 2017$3,369,000
-8.8%
68,064
+1.0%
0.00%0.0%
Q1 2017$3,695,000
-1.6%
67,421
+0.0%
0.00%0.0%
Q4 2016$3,756,000
+24.8%
67,418
+2.3%
0.00%0.0%
Q3 2016$3,010,000
+13.4%
65,906
-0.8%
0.00%0.0%
Q2 2016$2,654,000
+18.4%
66,441
+3.2%
0.00%0.0%
Q1 2016$2,242,000
-32.8%
64,378
-17.0%
0.00%0.0%
Q4 2015$3,335,000
+5.4%
77,598
+6.8%
0.00%0.0%
Q3 2015$3,165,000
-3.0%
72,682
+15.0%
0.00%0.0%
Q2 2015$3,262,000
+38.8%
63,226
+5.4%
0.00%0.0%
Q1 2015$2,350,000
+38.8%
59,996
+36.9%
0.00%
Q4 2014$1,693,000
+9.4%
43,823
-0.1%
0.00%
Q3 2014$1,548,000
-27.7%
43,857
-44.8%
0.00%
Q2 2014$2,142,000
+199.2%
79,486
+187.7%
0.00%
Q1 2014$716,000
+23.9%
27,626
+3.6%
0.00%
Q4 2013$578,000
+24.6%
26,661
+12.0%
0.00%
Q3 2013$464,00023,8020.00%
Other shareholders
BIOSPECIFICS TECHNOLOGIES CO shareholders Q1 2020
NameSharesValueWeighting ↓
APIS CAPITAL ADVISORS, LLC 36,000$2,244,0002.71%
JW Asset Management, LLC 73,649$4,591,0002.36%
THB ASSET MANAGEMENT 87,491$5,453,0000.79%
RICE HALL JAMES & ASSOCIATES, LLC 315,972$19,695,0000.63%
EAM Global Investors LLC 22,789$1,420,0000.63%
Elk Creek Partners, LLC 73,936$4,608,0000.33%
Matarin Capital Management, LLC 69,964$4,361,0000.32%
EAM Investors, LLC 17,696$1,103,0000.27%
CADENCE CAPITAL MANAGEMENT LLC 37,196$2,318,0000.21%
Cavalier Investments, LLC 7,800$486,0000.20%
View complete list of BIOSPECIFICS TECHNOLOGIES CO shareholders